Clinical Microbiology and Infection

Article	Citations
COVID-19 in special populations	735
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?	648
Corrigendum to “Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations” [Clin Microbiol and Infect 26 (1) (2020) 60–70]	431
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness	424
Outside Front Cover	416
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?	274
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)	254
Exploring the limits of interferon-γ releasing assay screening in large-scale populations	183
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review	173
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain	158
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study	157
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments	156
Re: ‘Dosing and route of administration of clindamycin given in combination with rifampicin’ by Magreault et al.	148
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples	141
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?	136
Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing	127
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models	108
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use	107
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections	104
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia	102
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response	102
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023	100
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing	99
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition	91
Re: ‘Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicentre study in France, 2008–2019’ by Leroux et al.	89

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	86
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi	86
‘Scope and aims of ESCMID guidelines’ by Scudeller et al.	84
Large language models for antibiotic prescribing—moving the needle from ‘parlour trick’ to practical tool	84
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate	84
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study	84
The importance of patient information and informed consent for unlicensed phage therapy	81
The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis	79
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections	78
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern	78
A randomised trial of simultaneous versus sequential pneumococcal vaccination in elderly	75
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20	71
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021	70
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)	68
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	68
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review	68
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?	67
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation	63
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis	63
Re: ‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’ by Kim et al.	62
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia	61
A chronic infectious bladder stone causing an obstructive emphysematous cystitis	60
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values	59
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies	59
One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis	58
Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study	58
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women	57
In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection	57
Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up	57
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia	56
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients	56
Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns	55
Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission	54
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial	54
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19	54
Clinical microbiology laboratories in low-resource settings, it is not only about equipment and reagents, but also good governance for sustainability	53
Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations	53
Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients	52
A strain uncoloured by Gram staining in a pleural fluid	52
Kinetics of the Alethia® malaria loop-mediated isothermal amplification (LAMP) positivity during post-treatment follow-up of patients with imported malaria	52
Nursing practice is associated with high risk for hepatitis C virus infection	52
Concurrent systemic antibiotics at catheter insertion and intravascular catheter-related infection in the ICU: a post hoc analysis using individual data from five large RCTs	52
Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model	51
The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort	50
A comparative evaluation of commercial boric acid containers for preserving microorganisms in urine specimens	49
Community adoption of protective behaviours: before and during the COVID-19 pandemic	48
The controversial bond between COVID-19 and bacterial superinfections	48
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents	48
A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection	47
Remdesivir for the treatment of COVID-19: author's response	47

Assessing prescription of antibiotics after vaccination against pneumococcal pneumonia; using prescription sequence symmetry analysis	47
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study	46
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa	46
Scope and aims of European society of clinical microbiology and infectious diseases guidelines: a white paper	46
Uncovering hidden transmission pathways of Klebsiella pneumoniae: is there a need to re-evaluate the necessity for toilet disinfection?	46
Effect of antiseptic bathing with chlorhexidine or octenidine on central line–associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial	46
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?	45
The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?	45
Inferring antibiotic susceptibility from metagenomic data: dream or reality?	45
Unexpected natural cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic background	45
Seeing is Believing	44
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women—a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)	44
Optimization of antiviral dosing in Herpesviridae encephalitis: a promising approach to improve outcome?	44
Fulminant cytokine release syndrome in a paediatric patient with refractory Epstein–Barr virus-associated haemophagocytic lymphohistiocytosis receiving nivolumab treatment	43
The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid	43
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial	41
Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019–2023	41
Steroids for viral meningitis: a foe or a friend?	41
Alternative therapies against Mycobacterium abscessus infections	41
Aortic 18F-FDG PET/CT hypermetabolism in patients with long COVID: a retrospective study	41
Accuracy of cholera rapid diagnostic tests: a systematic review and meta-analysis	41
Effect of a multimodal prevention strategy on dialysis-associated infection events in outpatients receiving haemodialysis: The DIPS stepped wedge, cluster-randomized trial	40
Removal of incorrect penicillin allergy labels in a UK hospital	40
Diagnostic accuracy of self-collected tongue swabs for Mycobacterium tuberculosis complex detection in individuals being assessed for tuberculosis in South Africa using the Xpert MTB/RIF Ultra assay	40
Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines	39
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection	39
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China	39
CMI: how did we do in 2020?	39
Which trials do we need?	39
Early switch to oral antimicrobials in brain abscess: a narrative review	38
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19	38
Predictors of laboratory-confirmed mpox in people with mpox-like illness	38
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort	38
Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations	38
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease	37
Late positivization of oropharyngeal, plasma, anal, semen, and urine specimens which tested negative at the time of mpox diagnosis	37
Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study	37
Performances of NeuMoDx™, a random-access system for hepatitis B virus DNA and hepatitis C virus RNA quantification	37
An overview of COVID-19 in solid organ transplantation	37
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply	36
Why don't we talk about tuberculosis stewardship?	36
Quo vadis clinical diagnostic microbiology?	35
Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States	35
Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settin	35
Real-life validation of a sample pooling strategy for screening of hepatitis C	35
Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic	35
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort	34
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024	33
High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: a prospective multisite cross-sectional study (ANRS COV11)	33
Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis	33
‘Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA COVID-19 vaccine compared to unexposed infants’ – author's response	33
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!	33
Decision letters from other journals	32
Antimicrobials are effective for treatment of uncomplicated urinary infection	32
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard	32
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan	32
Changing face of mpox	32
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility	32
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial	32
Blood culture bottles remain efficient months after their expiration date: implications for low- and middle-income countries	32
Diagnostic test accuracy of the Fungitell serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	32
Re: ‘ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults’ by Bodilsen et al.	32
Rice bodies in Brucellar tenosynovitis: a case report	31
Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates	31
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance	31
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	31
Lyme neuroborreliosis with encephalitis; a systematic literature review and a Scandinavian cohort study	31
Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic	30
Revisiting diagnostics: practical application of next-generation sequencing technologies for infectious diseases	30
Assessing the accuracy of a novel algorithm for group B Streptococcus detection in pregnant women and its impact on early-onset neonatal group B streptococcal infections	30
Using a difficult-to-treat resistance index to gauge imbalance between countries' antibiotic resistance prevalence and access to antibiotics: a scoping review and concept proposal	30
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort study	30
Exploring the dynamics of Borrelia burgdorferi sensu lato antibodies—a registry-based study on laboratory data from Sweden and Denmark	30
Are we enrolling the right patients? A scoping review of external validity and generalizability of clinical trials in bloodstream infections	30
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group	30
Availability and costs of medicines for the treatment of tuberculosis in Europe	29
How to use direct microscopy for diagnosing fungal infections	29
Re: predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19	29
A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages	29
‘Limitations of classification and regression tree analysis in vancomycin exposure-response relationship studies’ – Author's reply	29

The interface between COVID-19 and bacterial healthcare-associated infections	29
Unneeded antibiotics for acute respiratory infections in primary care: stop as early as possible	28
How to: improve peer review skills for CMI	28
COVID-19 vaccine: missed opportunities and hospital vaccine implementation	28
Sepsis: a summary of the SEP-1 quality measure and future considerations	28
Variability of antibiograms: how often do changes in the antimicrobial susceptibility pattern occur in isolates from one patient?	28
Long-term evolution of humoral immune response after SARS-CoV-2 infection	28
Re: ‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 infection in older Singaporeans’ by Wee et al.	28
Renal microsporidiosis due to Encephalitozoon cuniculi in an HIV/AIDS patient with persistent fever and kidney injury	28
Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden	28
Re: ‘Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients’ by Cornely et al.	28
Determining the effect of pneumococcal vaccination on antibiotic prescriptions: is prescription sequence symmetry analysis a valid approach?	28
Mortality and sequelae associated with regional use of intracranial devices among patients with pneumococcal meningitis: a nationwide, population-based cohort study	27
Pleural aspergillosis in an otherwise healthy patient diagnosed by medical thoracoscopy	27
ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata	27
Establishing piperacillin–tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurement	27
Seeing the whole elephant: designing ‘one health’ governance to fight antimicrobial resistance	27
Ceftaroline for methicillin-resistant Staphylococcus aureus bacteraemia: a magic bullet, a weight on the seesaw, or neither?	27
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial	27
First-generation oral antivirals against SARS-CoV-2	27
Integrating pre-test probability and β-D-glucan cut-offs to enhance accuracy in diagnosing pneumocystis pneumonia	27
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients	27
The tension between clinical and microbiological relevance in applying clinical trial results for Gram negative bacterial infections	27
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model	27
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian m	26
Re: ‘Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland’ by Garzoni et al.	26
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system	26
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study	26
The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study	26
Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection	26
Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules	26
Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation	26
Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China	26
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis	26
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 stud	26
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial	25
Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: author's response	25
A contemporary review of clade-specific virological differences in monkeypox viruses	25
Target trial emulation framework: mitigating methodological challenges and application in COVID-19 treatment evaluation studies	25
Escherichia coli community-acquired meningitis in adults: a case series of 29 patients in France	25
Massive furunculoid myiasis in a traveller after a trip to Uganda	25
Management of Gram-positive multiresistant bacteria prosthetic joint infection: a narrative review on current and innovative strategies	25
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study	25
Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization	25
Corrigendum to “Does SARS-CoV-2 re-infection depend on virus variant?” [Clin Microbiol Infect 27 (9) (2021 Sep) 1374–1375]	24
Decision letter from other journals and peer review	24
Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection	24
Sputum proteomic analysis for distinguishing between pulmonary tuberculosis and non-tuberculosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS): prel	24
Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination	24
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection	24
Refocus attention on HIV/AIDS: due to neglect during the COVID-19 pandemic	23
Factors associated with the detection of norovirus among asymptomatic adults	23
The challenge to improving and standardizing training in infectious diseases in Europe	23
Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled	23
Corrigendum to “Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model” [Clin Microbiol Infect 29 (12) (2023) P1600.e1–1600.e6]	23
Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis	23
Widespread circulation of pertussis in Finland during 1968–1972 when the whole cell vaccine was in use	23
Executive Committee	23
Early and better diagnosis for Lyme neuroborreliosis	23
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme	23
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up	23
Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France	22
Co-administration of COVID-19 and influenza vaccines	22
Comparative epidemiology of diarrhoeal organisms in high-risk adults using multiplex PCR gastrointestinal panel testing: a multicentre observational study	22
Septic pubic symphysitis: newest radiological, microbiological, and outcome findings in a rare and difficult-to-treat infection	22
Re: ‘Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard’ by Salzer et al.	22
Association of time to positivity with disease severity in bloodstream infections—a population-based cohort study	22
Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes	22
Confront cholera crisis after the Myanmar earthquake	22
Enhancing antimicrobial stewardship: recommendations to support implementation of the 2024 UN General Assembly political declaration on antimicrobial resistance	22
Safeguarding COVID-19 vaccines: establishing the safety of novel vaccine platforms	22
Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review	22
Are antimicrobial stewardship interventions effective and safe in long-term care facilities? A systematic review and meta-analysis	22
The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study	21
Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females	21
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data	21
Borrelia mayonii – A cause of Lyme borreliosis that can be visualized by microscopy of thin blood films	21
Antibiotic use prior to seeking medical care in patients with persistent fever: a cross-sectional study in four low- and middle-income countries	21
Factors associated with the appropriateness of antibiotics prescribed in French general practice: a cross-sectional study using reimbursement databases	21
Passive surveillance of Powassan virus in human-biting ticks and health outcomes of associated bite victims	21
Antibiotic resistance in Türkiye: what has been done and what needs to be done urgently?	21
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's response	20
Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis	20
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel	20
Mass screening strategy for the SARS-CoV-2 Delta variant outbreak in Guangzhou, May 2021	20
Infectious disease serology in 2021	20
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series	20
Bacteriophage therapy in humans	20
Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study	20
Smoking is associated with infection risk in healthy blood donors	20
Human alveolar echinococcosis–global, regional, and national annual incidence and prevalence rates	20
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1	20
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains	20
Population pharmacokinetics and dosing simulations of temocillin in liver-transplanted paediatric patients: a prospective, open-label, non-randomized study	20
An unusual paediatric case of post–kala-azar dermal leishmaniasis: a hidden parasite under the veil of white	20